| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Guyer William is a Chief Development Officer at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $116K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $35.30 | $353,000.00 | -62.3% | +72.8% | +108.2% | |
| Aug 1, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $38.67 | $386,700.00 | -62.3% | +23.6% | +81.9% | |
| Jul 1, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $32.49 | $324,900.00 | -62.3% | +41.7% | +112.2% | |
| Jun 3, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $32.00 | $320,000.00 | -62.3% | +9.5% | +122.1% | |
| May 28, 2024 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 30,000 | $32.00 | $960,000.00 | -83.2% | +10.7% | +145.7% | |
| Dec 22, 2023 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 10,000 | $32.00 | $320,000.00 | -60.1% | -24.5% | +56.9% |